U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07837648) titled 'A Study to Test How Much BI 3034701 Gets Into the Blood in Healthy People When Given in Two Different Ways' on Sept. 18.
Brief Summary: The aim of the trial is to investigate relative bioavailability of BI 3034701 treatment T vs. BI 3034701 treatment R.
Study Start Date: Oct. 05
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: BI3034701 formulation B
BI3034701 formulation B (reference treatment)
DRUG: BI3034701 formulation C1
BI3034701 formulation C1 (test treatment)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Disclaimer: Curated by HT Syndication....